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Abstract 
Background: Rupture of atherosclerotic plaques in the carotid circulation is one of the major 
causes of ischemic stroke. The recent risk-stratifier for evaluating stroke risk is based on area 
of lumen narrowing although recent research indicates that plaque components and 
morphology might be of greater importance. A lot of research is in progress with the aim to 
find a cost-effective and non-invasive imaging method that adequatly can detect plaque 
components associated with an increased risk of creating ischemic events. 
 
Objective: The aim of this systematic review was to evaluate the scientific evidence for 
which imaging method of CT and MRI that best identify carotid plaque components 
associated with an increased risk of creating ischemic events. 
 
Methods: Two literature searches (one for each imaging method) was performed in PubMed 
and Cochrane Central Register of Controlled Trials (CENTRAL). Inclusion criterias was 
defined and used to select relevant articles. Data were extracted and presented in tables. The 
quality of the individual articles was assessed. Statistical analyzes could not be performed. 
 
Findings: The literature search resulted in 648 articles about CT and 915 about MRI. 6 
articles about CT and 8 articles about MRI was included in the analysis. Direct comparisons 
between studies were not possible because of incomparable methods and outcome measures. 
Due to this it was not possible to perform any statistical analyze. Instead, a table highlighting 
the diversity between the articles was performed for each imaging method. However, the 
results indicated that MRI is a more researched method with better ability to identify plaque 
components than CT. 
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Interpretation: There is a significant gap in scientific knowledge on this subject. The 
researchers will need to agree on inclusion criterias, methods to perform imaging, and the use 
of outcome measures. A standardized list of recommendations of how to perform research on 
this subject needs to be established in this field. In combination with larger trials and 
representative populations, the results could be comparable, analyzes could be performed and 
conclusions be reliable. 
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Abbrevations 
AHA          American Heart Association 
CEA  Carotid endarterectomy 
CENTRAL  Cochrane Central Register of Controlled Trials 
CT  Computed tomography 
CVD  Cardiovascular diseases 
DSA  Digital subtraction angiography 
DSCT  Dual source computed tomography 
FC  Fibrous cap 
HU  Hounsfield units 
IPH  Intraplaque hemorrhage 
LDL  Low density lipoproteins 
LRNC  Lipid rich necrotic core 
MDCT  Multi detector computed tomography 
MRI  Magnetic resonance imaging 
NPV  Negative predictive value 
OCT   Optical coherence tomography 
PET  Positron emission tomography 
PPV  Positive predictive value 
QUADAS  Quality Assessment of Diagnostic Accuracy Studies 
ROC   Reciver operating characteristic 
SBU  Statens beredning och utvärdering 
SCM  Sternocleidomastoid muscle 
SMC   Smooth muscle cells 
US  Ultrasound 
WHO  World Health Organization  
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Background 
Cardiovascular diseases (CVDs) are the leading causes of death and decreased life quality in 
the world. According to the World Health Organization (WHO), CVDs caused 17.3 million 
deaths in 2008, where heart attacks accounted for 7.3 million deaths (46% of all CVDs) and 
stroke 6.2 million deaths (34% of all CVDs) (1).  
 
Stroke pathophysiology 
The pathophysiology of stroke includes different mechanisms essential for understandning the 
disease. The most common mechanism (87% of all strokes) is ischemic stroke, due to 
obstruction of an artery that serves the brain with blood resulting in ischemia of the tissue 
perfused by the artery (2). The other mechanism is bleeding due to rupture of weakened blood 
vessels within the brain resulting in an hemorrhagic stroke (13% of all strokes) (1, 2). 
Ischemic strokes is either caused by formation of a blood clot at the site of the damaged part 
of the vessel, a thrombus, or caused by formation of a blood clot in another part of the 
circulation, an embolus that travels with the blood to the brain where it occludes smaller 
vessels (2). These are usually formed in the vessels of the upper chest or the neck (usually the 
carotid arteries), or in the atrial chamber of the heart where fibrillation of the heart causes 
forming of blood clots with the potential of travelling with the blood to the brain.  
 
Atherosclerosis 
The main underlying pathogenesis for cerebrovascular diseases as well as for the diseases in 
the coronary arteries is atherosclerosis, a process affecting the large arteries. It is not a 
degenerative consequence of aging, but a slow, progressive disease that is characterized by a 
chronic inflammatory condition and formation of an atherosclerotic plaque within the artery 
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wall (3). It is a highly complex process where many conflicting theories exist about several 
stages in the development. Furthermore, most of the research is conducted on animals with 
questionable correspondence to the pathology in humans (4).   
 
Although, definite evidence of the details in the pathology is lacking, the major steps in the 
development of atherosclerotic plaques have been established. The process begin when 
changes occurs in the matrix of the vessel wall and the single cell layer covering the inner 
wall of the artery, the endothelium (4). This lets LDL (Low density lipoproteins) particles to 
attach to structures the inner layer of the artery wall, the intima (5). The LDL particles are 
oxidized into proinflammatoric molecules that stimulates inflammation within the artery wall 
(5). The inflammation recruites monocytes from the blood that engulf the lipids, and thereby 
they become foam cells (macrophages filled with lipids) (4). Eventually the foam cells die, 
which contributes to the forming of a necrotic core of the lipids leaking out from the foam 
cells (3). Cytokines released from inflammatory cells within the arterial wall, recruits smooth 
muscle cells (SMC) to the intima where they produce extracellular matrix that forms a fibrous 
cap over the necrotic core of lipids (4). This process continues within the arterial wall thus 
resulting in plaque formation that within time results in narrowing of the artery lumen.  
 
However, the fibrous cap can eventually weaken and rupture, thus exposing underlying tissue 
to the flowing blood and thereby initiate formation of a thrumbus or embolus (6).  Although 
atherosclerosis develops over decades, it has the potential to manifest in acute events causing 
dramatic and sudden clinical events. 
 
The vulnerable plaque 
According to WHO, CVDs are eminently available for preventive intervention with the aim to 
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reduce cost and health related burden both on individual and population level (1). 
There are several riskfactors known to contribute to the development and progress of CVD. 
The current most well-known risk factor for cerebrovascular events is high-grade luminal 
narrowing of the internal carotid arteries (7). Preventive actions like carotid endarterectomy 
(CEA) has shown to be beneficial for patients with symtomatic ipsilateral high-grade (70-99 
percent) internal carotid stenosis (8). The golden standard to measure the grade of the stenosis 
is Digital Subtraction Angiography (DSA)(9), although other methods such as duplex 
ultrasound is widely used in the clinic due to its simplicity and cost-effectiveness (10). Even 
though high-grade stenosis is an important risk factor for ischemic events, all patients will not 
experience clinical manifestations (7). Additionally, patients with low-grade stenosis can 
experience clinical manifestations. This has lead to a growing interest of other factors than the 
degree of the stenosis determining the risk of plaque rupture. A new concept of the vulnerable 
plaque has developed, where the emphasis has shifted to focus on plaque composition, 
morphology and structure as determinants of risk for rupure and clinical events (7, 11-18). 
 
Histological classification 
The golden standard to examine plaque morphology is by histology (18, 19). In 1995, the 
consensus group of the American Heart Association (AHA) published a report which 
describes components and pathomechanisms of coronary plaques detected by histology and 
correlated to clinical symtoms (20). The content of the report is a histological classification 
that is still widely used to classify plaques based on composition and morphology. Plaques or 
lesions are divided into eight groups (see table 1) graded from precursor lesions (I-III) to 
advanced lesions (IV-VIII) (20).  
 
 
 9 
Table 1. Description of plaque types according to the AHA classification scheme.  
Plaque type Description Characterization 
I Thickening of the intima layer of the vessel Precursor lesion 
II Presence of a fatty streak Precursor lesion 
III Transitional/intermediate lesion (preatheroma) Precursor lesion 
IV Core of extracellular lipid with well-defined 
region of the intima (atheroma) 
Risk of rupture 
V Fibrous connective tissue overlying the lipid core  
(fibroatheroma) 
Risk of rupture 
VI Complicated plaques with surface defects, and/or 
hematoma-hemorrhage, and/or thrombosis 
(complicated lesion) 
Risk of rupture 
VII Calcified plaque  Stable lesion 
VIII Fibrotic plaque without a lipid core and with 
possible small calcifications 
Stable lesion 
 
Three lesions types (IV-VI) were considered to be relevant in this thesis since these are 
associated with highest risk of rupture. The type IV lesion, the atheroma, is characterized by a 
severe disorganization in the intima caused by the accumulation of extracellular lipids thus 
forming a lipid core in the vessel wall. Type V, the fibroatheroma, is characterized by a 
fibrous cap covering the lipid core. It can be of various thickness, sometimes even thicker 
than the underlying lipid acculumation and consist of a an increased amount of smooth 
muscle cells and collagen. Type VI, the complicated lesion, develops from type VI or V when 
surface defects like ulceration or fissures occur, causing hemorrhage or thrombus formation 
within the plaque. In summary, there are three components that distinguish these three groups: 
the LRNC (Lipid Rich Necrotic Core) for type IV, the FC (Fibrous Cap) for type V and the 
IPH (Intraplaque Hemorrhage) for type VI.  
 
Even though the AHA report is based on examination of coronary plaques, it is convenient to 
use the same classification scheme for carotid plaques since the mechanisms behind plaque 
instability are similar to those in the coronary circulation (13, 20, 21).  
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Imaging methods 
The shift of focus to the concept of the vulnerable plaque has created a need for new imaging 
techniques since DSA provides no information of plaque composition (17). There is a need to 
find non-invasive, fast and cost-effective imaging methods that gives information about 
plaque composition and morphology. The current most well studied methods are Computed 
Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasound (US). Although 
other methods, for example Positron Emisson Tomography (PET-scan), Optical Coherence 
Tomography (OCT) and different molecular imaging methods, are also being studied. This 
thesis focuses on CT and MRI. 
 
Computed Tomography (CT) 
CT is a technique using special x-ray beams that are submitted through the patient and 
detected by sensors. These signals are analyzed by computer that with complex mathematical 
algorithms enable image reconstruction (22). Different components are differently attenuated, 
which is measured in Hounsfield Units (HU). Based on the the large amout of measurements 
of attenuation coefficients, the image can be reconstructed in the computer. The beams and 
the sensors register while physically moving around the patient which enables reconstruction 
of 3D images. In order to visualize blood vessels, CT angiography can be used. This 
technique will scan the patient while a contrast material (usually iodine) is injected through a 
catheter in a vein (23).  
 
Recently, several new types of CT scanners has developed. Multislice CT scanners (MDCT), 
which allows multiple slices to be imaged in a shorter period of time. Dual source computed 
tomography (DSCT) uses two X-ray source/detector systems that rotate simultaneously 
around the patient. The use of different energy levels gives high temporal resolution and the 
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time required is almost the half compared with conventional CT (24). Although these 
methods gives more detailed information on tissue components, the radiation dose is 
controversial (25). 
 
Magnetic Resonance Imaging (MRI) 
The human body consist of a large amount of hydrogen atoms. When placed in a magnetic 
field, these hydrogen atoms are aligned with it. By disturbing the atoms with radiowaves, the 
polarity changes. Depending on the water content of the tissue, the time for the atoms to 
return to their original position varies and this time is detected by a sensor. Since different 
tissues contain different amount of water, they will give different signals (26). The signals are 
interpreted by a computer that processes and converts these to images of different black-white 
scales. In the MRI hardware, different types of coils are used as the receivers or transmitters 
for MRI signals. Depending on the volume of the examined tissue, different coils can be used 
to improve the resolution (27). 
 
Objectives 
A lot of research is in progress to find non-invasive imaging methods that can detect high-risk 
components within the plaque. By studying the correlation of components detected with 
imaging methods and histology, the direct correlation between morphology and the ability of 
the imaging methods to identify different components is evaluated. 
 
The aim of this review was to evaluate the scientific evidence for which imaging method of 
CT and MRI that best identify carotid plaque components associated with an increased risk of 
creating ischemic events. 
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Significance of study 
If non-invasive methods adequately can detect components associated with an increased risk 
of creating ischemic events, the management of atherosclerotic disease would be facilitated. 
Cost, time of procedure and health risks related to invasive procedures would be diminished. 
It might also lead to identification of new components that could not be visualized by 
previous methods. This review will hopefully contribute to increased knowledge and 
development of non-invasive imaging methods. In the future, imaging methods could be used 
to screen populations to identify atherosclerotic plaques with higher risk of creating ischemic 
events and thereby preventive actions could be taken to prevent disease.  
 
Method  
Information on the subject was collected through hand-search on the internet and in textbooks 
in neurology and neurosurgery. Two PIRO (a modifed PICO structure including Population, 
Index test, Reference test and Outcome), one for each imaging method, was determined (see 
table 2). 
Table 2. Two PIRO questions were set up to define the issue of the thesis.  
 PIRO 1 PIRO 2  
Population Patients with carotid plaques Patients with carotid plaques 
Index test  CT MRI 
Reference test Histology (PAD) Histology (PAD) 
Outcome  
Agreement (Specificity, 
Sensitivity etc.) 
1) type IV plaque 
2) type V plaque 
3) type VI plaque 
Agreement (Specificity, Sensitivity 
etc.) 
1) type IV plaque 
2) type V plaque 
3) type VI plaque 
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Eligibility criteria 
Inclusion criterias were set up equal for the two PIRO questions. Only articles in english were 
determined to be included. Concerning article age limit, it was initially set to include articles 
published in the last 5 years but was changed to the last 10 years. The reason for this was that 
a significant amout of relevant literature published in the mid 2000 was found and a relatively 
small amount in the last 5 years. Study characteristics was set up to patients over 40 years in 
order to exclude studies of hereditary atherosclerotic diseases. The number of patients was 
limited initially to >25 patients. This limit had to be ignored for PIRO 1 (CT) during the 
selection process due to a small amount of literature that matched this criteria (see section 
study selection). All other articles other than original articles were excluded. Studies 
performed on coronary arteries and not concurrent with existing PIROs were excluded. 
Studies performed on ex-vivo plaques, meaning imaging by CT or MRI after plaque 
extraction, were excluded. Inclusion and exclusion criterias are summerized in table 3.  
Table 3. Inclusion- and exclusion criterias 
Inclusion criterias 
 
Exclusion criterias 
English language articles Reviews, case reports, editorials etc. 
Published latest 10 years (2004-2014)* Studies performed on coronary circulation 
Patients >40 years  Not concurrent with PIRO 
Studies with >25 patients** Ex-vivo characterization 
* This limit was initally set to 5 years but was changed after the first literature search. 
** This limit was ignored for PIRO 1 (CT) during the selection process. 
 
Literature search 
The literature search was performed in two databases, the Cochrane Central Register of 
Controlled Trials (CENTRAL) and Pubmed. For each studied imaging method, one literature 
search was performed in each database. Thus, resulting in four separate literature searches. 
Different keywords was used based on the PIRO structure except keywords for O (outcome) 
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which were excluded. The search included MeSH-terms (the vocabulary for indexing articles 
used by a range of medical databases) and free-text words in order to include all recently 
published articles missing a MeSH index. These terms were combined with the Boolean 
operator OR for each group of the included PIRO (Population, Indextest and Referencetest) 
and the final search string was set up by combining the groups with the Boolean operator 
AND.  
 
Study selection 
Studies were selected according to the predetermined inclusion criterias. First by reading 
titles, then abstracts and finally full-text articles. When issues came up that had not been 
considered in advance, thus not mentioned in the inclusion criterias, a modification of these 
was performed. When sorting out articles for PIRO1 (Computed Tomography) the inclusion 
criteria for number of patients had to be changed since it showed only a few number of 
articles matched the criteria. Concerning MRI, a significant amount of studies included over 
25 patients thus the limit was respected. 
 
Articles read in full-text were screened for additional references. In addition, two prominent 
researchers within field was contacted and asked for additional references. These articles were 
read and sorted by relevance first by title and abstract, followed by full-text. All additional 
references read in full-text was reported. In order to overview the selection processes, a flow 
diagram ”Preferred Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA) 
was used for each PIRO. 
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Data extraction and presentation 
When articles were assessed for relevance and suitable for inclusion, data were extracted and 
presented in tables with individual support from Ola Samuelsson at HTA-centrum (the Health 
Technology Assessment at Sahlgrenska University Hospital). Headlines used was 
author/year/country, study design, number of patients/plaques, dropouts, gender, 
mean/median age, type of patients (symtomatic/asymtomatic), diagnostic test (Index vs 
Reference), use of contrast agent, outcome variables reported in the study, translated AHA 
type, time between index and reference test, measurement of agreement and quality of study. 
For each outcome variable (AHA type IV, V and VI) and PIRO (1 and 2) an inclusion table 
was performed.  
 
The outcome variables consists of the three AHA groups IV, V and VI which are 
characterized by specific histological components (see background, histological 
classification). In a significant proportion of the included articles, the study variables were not 
presented in AHA groups or components directly correlating to the groups. To enable 
comparison, these had to be transformed by the author into as comparable components as 
possible with support from table 1. Therefore outcome variables as reported in the study and 
the translated type are presented in the inclusion tables. 
 
Risk of bias in individual studies 
The quality of the articles was evaluated with support of the template Quality Assessment of 
Diagnostic Accuracy Studies (QUADAS) for assessing quality of articles from SBU (Statens 
Beredning och Utvärdering). The template was modified to suit the actual scientific issue thus 
resulting in exclusion of three questions from the original template. One question concerning 
conflicts of interest (see modified template in appendix) was added. The basis for assessment 
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of the individual questions was set up before the quality was validated. A patient spectrum 
bias was defined to exist if the study did not include both symptomatic and asymptomatic 
patients. A disease progression bias was defined to exist if the mean time between the index 
and reference test exceeded 30 days. The template was applied for each one of the included 
studies for PIRO 1 and 2 and the quality was determined as high/moderate/low.  
 
Data analysis 
Two aspects were considered in the analysis of the included articles; outcome measures and 
the methodological approach. Outcome measures were presented in analyze tables for each 
outcome and PIRO. The variable/variables used to analyze the agreement between imaging 
and histology and the inter-/intraobserver agreement was presented. The methodological 
approach was presented in one table for each PIRO highlighting the overall technical 
differences concerning imaging technique and differences in the analysis of plaque. Headlines 
used for PIRO 1 was Author/Year/Country, Method to measure density, Method to define 
density, Landmarks used to match histology and imaging slices, Method of CEA, Extraction 
of calcium during image processing, Contrast administration and Method of histologic 
assessment. Headlines used for PIRO 2 was Author/Year/Country, MRI protocool, Contrast 
administration, Method to detect components, Landmarks used to match histology and 
imaging slices, Method of CEA and Method of histologic assessment. 
Ethics 
This systematic review consists of data retrieved from published scientific articles and 
therefore did not require consideration of ethical issues. The purpose is to elucidate an up-to-
date and new perspective on the subject in order to approach the aim of finding a better 
method of assessing atherosclerotic disease. This might improve the selection of patients for 
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preventive actions in the future and therefore decrease the mortality and morbidity of 
ischemic stroke. 
Results  
Study selection  
PIRO 1 Computed Tomography (CT)  
The literature search generated 648 articles (640 in pubmed and 8 in CENTRAL) (search 
tables for each database are provided in the appendix, table 4 and 5). Two prominent 
researchers in the field was contacted and asked for additional record which resulted in 3 
additional articles. Records were screened for duplicates which resulted in exclusion of 2 
articles. Then articles were read by title followed by abstract and all articles not matching the 
inclusion criterias was excluded which resulted in exclusion of 626 articles. Thereby, 25 
articles remained to be read in full-text. All articles read in full-text were screened for 
references by reading first title then abstract, which resulted in 2 additional references 
matching the inclusion criterias. (see appendix for additional references, table 6, and flow 
diagram, figure 1, for selection of articles). 19 of the 25 articles read in full-text were 
excluded (see appendix, table 7, for reasons of exclusion). 6 articles remained to be included 
in the analysis.  
 
PIRO 2 Magnetic Resonance Imaging (MRI) 
The literature search resulted in 915 articles (892 in pubmed and 23 in CENTRAL) (search 
tables for each database are provided in the appendix, table 8 and 9). Records were screened 
for duplicates which resulted in exclusion of 5 articles. Then articles were read by title 
followed by abstract and all articles not matching the inclusion criterias were excluded which 
resulted in exclusion of 888 articles. Thus, 25 articles remained to be read in full-text. All 
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articles read in full-text were screened for references by reading first title then abstract, which 
resulted in 3 additional references matching the inclusion criterias. (see appendix, table 10, for 
additional references and flow diagram, figure 2, for selection of articles). 17 of the 25 articles 
read in full-text were excluded (see appendix, table 11, for reasons of exclusion). 8 articles 
remained to be included in the analysis. 
 
Quality assessment of included studies 
PIRO 1 Computed Tomography (CT) 
The quality was overall acceptable for all 6 included studies. One article (17) was assessed as 
low quality and 5 as moderate quality (contact author for full information about quality 
assessment of each article). All studies declared reasons for droputs. 3 studies did not include 
both symptomatic and asymtomatic patients, thus only 3 studies included a representative 
population. In 4 studies, pathologists were blinded for the results of the indextest (CT) while 
the radiologists were blinded for the reference test (histology) in 2 studies. No study reported 
non- interpretable results. The risk of conflicts of interest affecting the result was determined 
as non-existent in 4 studies while it was unclear in 2 studies.  
 
PIRO 2 Magnetic Resonance Imaging (MRI) 
The quality was overall good for all 8 included studies. One article (28) was assessed as being 
of low quality, 5 as moderate and 2 articles (29, 30) as high (contact author for full 
information about quality assessment of each article). All studies declared reasons for 
droputs. 5 studies did not include both symptomatic and asymtomatic patients, thus only 3 
studies included a representative population. In 2 studies, pathologists were blinded for the 
results of the indextest (MRI) while the radiologists were blinded for the reference test 
(histology) in 4 studies. No study reported non-interpretable results. The risk of conflicts of 
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interest affecting the result was determined as non-existent in 5 studies while it was unclear in 
3 studies.  
 
Study characteristics 
PIRO 1 Computed Tomography (CT) 
Inclusion tables for the three outcome variables (AHA type IV, V and VI) are provided in the 
appendix (table 12, 13 and 14). The studies showed overall many differences regarding 
several aspects. However all studies were cross-sectional. Contrast agent was used in all 
studies, but varied between Iodine, Iodine+Saline chaser and Iopamidol. In two studies 
specific agent was not reported. Number of patients varied between 8 and 51. Number of 
dropouts varied between 0 (in a study with 8 patients(15)) and 39 (in a study with 51 
patients(14)). All studies included a significant larger number of men than women. The mean 
age varied between 62 and 71.4 years. 3, out of 6, studies included both asymtomatic and 
symtomatic patients. MDCT was studied in all studies except one (17) where DSCT was 
studied. The outcome was reported in AHA types in 3 studies although one had studied type 
IV and V as the same outcome (17). The outcome in the other 3 studies was translated into 
suitable AHA types by the author. The time between the index test and reference test varied 
between 2 days (17) and 3 months (16).  
 
PIRO 2 Magnetic Resonance Imaging (MRI) 
Inclusion tables for the three outcome variables (AHA type IV, V and VI) are provided in the 
appendix (table 15, 16 and 17). The studies showed overall many differences regarding 
several aspects. However all studies were cross-sectional. Contrast agent (Gadolinum) was 
used in one study (31). Number of patients varied between 27 and 70. Number of dropouts 
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varied between 0 (in a study with 35 patients (32)) and 38 (in a study with 70 patients (33)). 
All studies included a significant larger number of men than women. The mean age varied 
between 67.7 and 71 years. 4 studies included both asymtomatic and symtomatic patients, 2 
included only symtomatic patients (28, 32) and 2 had not specified prevalence of symptoms 
(30, 31). 1,5 T MRI was used in all studies but the use of coil types varied. The outcome was 
reported in AHA types in one study (32) but translated to AHA types in the remaining 8 
studies. The time between index test and reference test was 7 days in five studies, 20.5 in one 
study (32) and not reported in 2 studies (28, 34).  
 
Agreement analysis 
Outcome measures 
PIRO 1 Computed Tomography (CT) 
Analyze tables for each outcome variable are provided in the appendix (table 18, 19 and 20). 
The overall agreement of outcome measures showed a significant heterogenity. Density was 
presented in Hounsfield Units (HU) in all but one study (14) where it was presented with 
ΔHU (difference in HU between early and late phase contrast). The cut-off value for 
differentiation between components showed little conformance since it was measured 
between a variety of components and with variable methods. A variety of outcome measures 
was used, 2 studies analyzed the agreement with coefficient of determination (R2) (15, 16), 
one with Pearson correlation coefficient (14), 2 with Cohen’s kappa (15, 17) and 2 with 
sensitivity and specificity (35, 36). Only one study presented interobserver variability 
(between different radiologists) (16) while no study presented intraobserver variability 
(multiple assessments of one radiologist).  
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PIRO 2 Magnetic Resonance Imaging (MRI) 
Analyze tables for each outcome variable are provided in the appendix (table 21, 22 and 23). 
The overall agreement of outcome measures shows a fairly significant heterogenity. Cut-off 
values were presented for 2 studies (33, 37).  In one study (31) plaque enhancement (after 
contrast administration) was compared with plaque composition by comparing MRI images 
with histological slices obtained after extraction and presented with fractional plasma volume, 
Vp and transfer constant, Ktrans. In another study (33) the signal intensity was defined from 
comparison with a reference material. Different weighted images were not specified in all 
studies. In one study (37) the outcome measures were defined separately for each sequence. A 
variety of outcome measures were used, 2 studies analyzed agreement with Pearson 
correlation coefficient (r) (30, 31), one with a Bland-Altman plot (28), 2 with Cohen’s kappa 
(29, 30) and 4 with sensitivity/specificity (one also with Positive Predictive Value (PPV) and 
Negative Predictive Value (NPV)). 5 studies presented interobserver variability and 3 studies 
presented intraobserver variability.  
 
Methological approach 
PIRO 1 Computed Tomography (CT) 
Tables of diversity are provided in the appendix (table 24). The overall agreement of 
methodology varied significantly. The method to measure density varied significantly from 
manual to computerized processing of images and in 2 studies both methods were used (15, 
16). Furthermore, the method for analyzing density manually varied (only 2 studies used the 
same method (35, 36)). Concerning the studies using computerized software, one study (16) 
used a custom made plug-in software (ImageJJ) while the other (15) used an algorithm 
specifically developed for this study. Regarding methods to define density, one study used 
predefined Hounsfield values to define different components (17) while 4 studies measured it 
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after imaging. 4 studies reported cut-off values to distinguish between components, two by 
performing ROC (Reciver operating characteristic) analyzes (35, 36) one based on the 
predetermined values (17) and one by determining the halfway attenuation between mean 
densities for each components (15). In 4 studies, the carotid bifurcation was used as a 
landmark to match histologic and imaging slices. 2 studies did not report this parameter (14, 
17). No study reported the method of how the CEA was performed. Extraction of calcium was 
performed in one study (14). Standardized protocols for contrast administration was used in 3 
studies. 2 studies used a test bolus technique (15, 17), one assessed peak enhancement after 
graphical presentation at the aortic arch to optimize the timing of images to contrast 
enhancement (17). Histological assessment of components was performed manually in all 
studies.  
  
PIRO 2 Magnetic Resonance Imaging (MRI) 
Tables of diversity are provided in the appendix (table 25). The overall agreement of 
methodology varied significantly. 3 studies used standardized protocols to perform MRI 
although only one of these had specified type of protocol (30). One study (31) quantified 
contrast agent dynamics by using a generalized kinetic model for dynamic contrast enhanced 
MRI imaging. The remaining 4 studies did not specify how the imaging was performed. Only 
one study (31) used contrast agent (gadolinium-based). The method to measure density varied 
significantly from manual to computerized processing of images and in 2 studies both 
methods were used (28, 37). Although 5 studies used the sternocleidomastoid (SCM) muscle 
as reference tissue for determining components, one study (32) did not report method to 
detect components. 5 studies used the carotid bifurcation and the shape of the lumen as 
landmarks to assure correlation between imaging- and histology slices. 3 studies did not 
report landmarks. 2 studies specified how the CEA was performed (32, 33). Histological 
assessment of components was performed either manually, with computerized methods, or 
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with a combination of these. In addition, all studies used different manual methods as well as 
different software for computerized analyze when analyzing components.  
 
Synthesis of results 
No GRADE-analyze or meta-analysis could be performed due to major differences between 
studies regarding methods. This review also found an inconsequent use of outcome measures. 
This inherent heterogenity made statistical analyze impossible to perform. Although there are 
indications (as described above in study characteristics, quality assessment of included 
studies) that MRI is a more explored method to image atherosclerotic plaque components. 
This will be discussed further in discussion and conclusion. 
 
Discussion and conclusion 
In this review, 6 articles about the agreement between CT and histology and 8 articles about 
MRI and histology was included in the analysis. However, the results were highly variable 
and direct comparisons between studies were not possible because of incomparable methods 
and outcome measures, thus no meta-analysis or statistical analyze was performed. Although, 
results indicate MRI being a more explored method with better ability to identify carotid 
plaque components, which corresponds well with recent knowledge (38, 39). 
 
Overall, a significant amount of essential data was not presented or specified in some studies 
of both CT and MRI, as for example blinding, prevalence of symtoms and dropouts. 
Furthermore, a small number of patients were generally included, which obstruct the 
implementation of strong statistical analyses with tight confidence intervals. These factors 
weaken the overall scientific reliability in the field, which indicates that larger trials of better 
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quality are needed.  
 
Methodological considerations and suggestions for future studies 
Designing the scientific issue 
In the process of defining the question at the beginning of this review, a lot of literature in the 
field was studied in order to set up the right question. It generated a very low number of 
studies examining both CT and MRI against histology. Therefore, the issue of this review was 
divided into two separate questions, one for each index test (CT and MRI) but with the same 
reference test (histology) in order to get sufficient material to analyze. The aim was to 
compare the imaging methods, but since the literature searches were performed separately for 
each issue, the studied populations varied between studies of CT and MRI which reduced the 
comparability between the two imaging methods. Furthermore, a low amount of literature was 
found validating imaging methods with histology but the literature search generated a 
significant amount of literature correlating vulnerable components detected by imaging 
directly to stroke incidence. Excessive effort should in the future studies be invested to study 
previous research and understand the field to facililtate designing of the issue. A well-
designed issue enable the finding of more relevant answers and facilitates the work process.  
 
Literature search 
The literature search resulted in a larger number of articles about MRI than CT even though 
the limit for number of patients was reduced for CT. This indicates that MRI is a more well 
explored method since many more articles have been published in the field. As an indicator of 
the adequacy of the literature search, a large number of articles when screening reference-lists 
for articles read in full-text were already identified in the primary search results. This 
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indicates that the literature search probably included most of the relevant articles on the 
subject.  
 
Quality of individual articles 
Concerning assessment of quality in individual articles, blinding and time between index test 
and reference test were two factors affecting the quality. The assessment generated better 
results for MRI (2 studies assessed as high quality) than CT (no studies assessed as high 
quality) with a higher prevalence of blindning for both index test and reference test, thus 
indicating a stronger scientific approach in studies of MRI. Regarding time between index test 
and reference test, results varied strongly for CT (2 days to 3 months) but less for MRI (2 
days to 20.5 days). Since atherosclerosis has a dynamic development and prevalence of 
different plaque components i.e. IPH can vary over short time, it is of great importance that 
time between imaging and extraction of plaque during CEA is as short as possible. In all 
included articles, it was not specified if time between tests were between imaging and CEA or 
imaging and microscopic examination by a pathologist. It is unlikely to assume CEA and 
histology were performed at the same point, although only information of when CEA was 
performed is relevant since plaque components are fixed in formalin after extraction and 
thereafter the risk of change in plaque components is non-existent. Due to practical reasons it 
is often not possible to perform the CEA directly after imaging, although it is of great 
importance that this time is kept as short as possible. Also, more detailed information of time 
aspects should be reported.  
 
Eligibility criteria 
Inclusion criterias for both CT and MRI varied significantly between included studies. The 
criteria for a representative population in this study was set up to include both asymtomatic 
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and symtomatic patients, although results showed only a limited number of studies examining 
both these groups. There is an existing gap in scientific knowledge concerning components in 
plaques in patients with asymtomatic stenosis and patients with lumen narrowing < 70 % (40). 
If further research examined asymtomatic patients and patients with low grade stenosis in the 
same manner as symtomatic patients and patients with high-grade stenosis, a lot of knowledge 
would be obtained on this issue. 
 
Factors considered in the analyzing process  
If the method to extract plaques during CEA is performed without a uniform preparation and 
reporting system, it might result in artifacts of plaque features such as ruptured fibrous cap or 
hemorrhage (32). However, in the articles included in this review, no studies with CT and 
only 2 studies with MRI (32, 33) reported the technique for plaque extraction. When 
comparing imaging slices with histology the correlation is of importance to ensure that the 
same area is analyzed. Reported landmarks used as reference were more similar in studies of 
MRI than CT, which indicate that studies of MRI used more equal methods than studies of 
CT. 
 
Regarding the extraction of calcium, it is considered a factor affecting the enhancement of 
other components of the plaque when studying CT (41, 42). Although, only one study 
extracted calcium before analyzing the images (14). To obtain representative images, 
extraction of calcium should therefore be obtained.  
 
Another considerable factor is which type of CT (MDCT and DSCT was used in the analyzed 
articles) and which radiation dose is being used. As mentioned in the background, this subject 
is a highly debated issue. There are evidence that DSCT produces comparable or  lower 
radiation doses than conventinal CT (43). On the other hand, the radiation dose of both 
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MDCT and DSCT has to improve before it can proceed to clinical trials (44, 45) due to 
etchical dilemmas. Although, DSCT offers advantages over conventional MDCT with a 
reduction in radiation dose (45). MRI uses no radiation to obtain images which is a significant 
advantage for this type of imaging. If some of these methods will be used as a screening tool 
for high-risk atherosclerotic plaques in the future, a low radiation dose is of major importance 
to enable repeated examinations during a long time period.  
 
Furthermore, a large amout of preclinical studies examining plaques ex vivo (imaging 
performed after CEA) was found in the literature search and reference lists. There are several 
aspects differing ex vivo from in vivo plaques such as affection of formalin fixation (46), use 
of contrast (42) (which is not available in ex vivo studies) and plaque shrinkage due to 
changes in content when extracted from the body (30). In this study, studies performed ex 
vivo were excluded (see section Method, eligibility criteria) since data from these studies 
cannot be compared directly with studies performed on humans. However, there is a lot of 
knowledge in this field that should be considered when performing clinical studies. 
 
 
Definition of plaque components 
An important factor to enable comparison between studies is how the components are defined 
in both imaging and histology. Some studies used the AHA criterias while other used 
different terms for describing the content of the plaques. Since translation of described 
contents had to be performed (as described in the section method), it may have affected the 
results of how plaques were classified. As an example, in studies reporting fibrous tissue, it 
was translated to fibrous cap, AHA type V, which might affect the results since the reported 
fibrous tissue was not defined if it was covering the LRNC or acting as an underlying 
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component.  
 
The process to define components in CT and MRI images, was performed either manually, by 
automated computerized algorithms or with a combination of these. There are several 
advantages of using computerized methods, among these time saving and improvement of 
interrater variability (47). Recent research indicate it might also improve reproducibility and 
be of interest in longitudinal studies of progression of atherosclerotic disease (15). Although, 
the included studies in this review used completely different algorithms, which makes 
comparison between studies impossible. If the research in the field could agree on the use of a 
common software, comparison of detected components would be made possible.  
 
In order to define components, some studies about CT had predefined HU values for different 
components while some studies visually estimated components before defining ranges of HU 
values. This leads to large differences in how components are defined, which further weakens 
comparison between studies. In studies of MRI, a reference tissue was defined (in the 
majority of studies, the sternocleidomastoid muscle (SCM) was used). Provided SCM is an 
acceptable reference with small variations between patients, the results for MRI are more 
comparable than CT. 
 
 
Gap in scientific knowledge 
There seem to exist a significant gap in scientific knowledge within this area. A lot of 
research has been published correlating vulnerable components directly with clinical 
symtoms. Since histology is considered to be the golden standard of determining components 
(18, 19), this area should be further explored to establish the state of the scientific knowledge. 
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A tool for approaching this aim is to agree on the basis for how to perform studies of imaging 
and histology. In 2005, Lovett et al published a review (48) of different imaging methods 
examining carotid plaques compared with histology. The results were highly variable, even 
between studies using the same criterias for the imaging method. Therefore, direct 
comparisons between studies were not possible because of incomparable methods and 
interpretation of the results. Based on these results Lovett et al, proposed a list of 
recommendations for how studies of carotid plaque imaging versus histology should be 
performed and reported. It consists of 8 items concerning sample size, the presence of 
symtoms, time interval beween index test and reference test, detailed information of plaque 
processing, blinding, histological methods and report of certain components.  
 
Although these gudielines were published 9 years ago, the results in this thesis indicates that 
recent studies are not following these recommendations to any significant extent. The 
researchers need to agree on inclusion criterias, methods to perform imaging and the use of 
outcome measures. An updated recommendation, performed by a well-established and trusted 
organization, needs to be implemented in this field. In combination with larger trials and 
representative populations, the results would be comparable, analyzes could be performed and 
conclusions would be reliable. Not until then can non-invasive imaging methods be used in 
the clinic to prevent progression of atherosclerotic disease. 
 
Limitations 
Because of the importance of an appropriate study selection, at least two reviewers should be 
involved in order to ensure a high quality of the review (49). Since this review was performed 
by one reviewer, this might have affected the results of the selection process and 
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interpretation of the results. Continuous contact with the Library of Gothenburg University 
and Health Technology Assessment Department (HTA-centrum) at the Sahlgrenska 
University Hospital was maintained to ensure a systematic and transparent approach during 
the process. It is desirable for future reviews to be conducted by two or more reviewers to 
enhance the quality of the review. Furthermore, a deeper technical knowledge of radiological 
methods and performance of systematic reviews would significantly facilitate the work.  
 
A well designed scientific issue is of great importance when working with a systematic 
review (50, 51). A well validated question leads to a low risk of need to change criterias and 
methods along the process. In this review, two inclusion criteras had to be changed after the 
literature search (see section Method, egliability criterias) which is not desirable. This sligthly 
diminish the transparent and systematic approach of this review since the risk of subjective 
conclusions after performing the literature search cannot be excluded. Therefore, future 
studies need to enhance the focus on the initial stages of designing a review in order to obtain 
the systematic approach thoughout the whole process.    
 
In this review, only two databases were used (pubmed and CENTRAL). Even though these 
are considered to be comprehensive in the medical field, more databases, both medical and 
technical should be considered, as this would probably increase the size of the material which 
might lead to the finding of more articles of relevance.   
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Populärvetenskaplig sammanfattning 
Åderförkalkning är ett mycket vanligt tillstånd som ökar med åldern och beror på inlagringar i 
våra blodkärl, även kallat plack, som bland annat består av fett, bindväv och blodkroppar. En 
konsekvens av åderförkalkning är att blodproppar bildas, vilket leder till syrebrist till olika organ 
beroende på var åderförkalkningen sitter. Stroke är en av de vanligaste och allvarligaste 
konsekvenserna av detta och innebär att syretillförseln till hjärnan är påverkad. Halskärlsartärerna 
är en vanlig plats där åderförkalkningen sitter som orsakar stroke. 
 
Metoden man idag använder för att undersöka om man har plack som har ökad risk att orsaka 
stroke bygger på att man mäter hur stor del av kärlets innerdiameter som utgörs av plack. Detta är 
avgörande när man bestämmer om man ska utföra förebyggande åtgärder som exempelvis att 
operera bort ett plack. Ny forskning pekar dock på att förekomsten av olika komponenter i placket 
har större betydelse för risken att drabbas av stroke. Om man kan hitta en undersökningsmetod 
som inte är riskfylld för patienten, som med tillräcklig säkerhet kan ge information om 
komponenter med ökad risk att orsaka stroke, kan förebyggande insatser leda till minskat lidande 
och dödlighet i stroke. 
 
I denna studie sammanställdes artiklar från studier som undersökt hur väl Datortomografi (DT) 
och Magnetröntgen (MR) kan avbilda komponenter som man i tidigare forskning har kopplat till 
ökad risk för stroke som konsekvens av åderförkalkning. För att inkluderas i studien ska 
komponenterna jämföras med vävnadsprov, vilket innebär att placken efter bildtagning opererats 
bort och analyserats i mikroskop. Sammanställningen är gjord på ett systematiskt och strukturerat 
sätt där varje steg i analysen har beskrivits för att säkerställa kvalitén. 
 
 Resultaten pekar på att underlaget är för magert för att kunna dra väl underbyggda slutsater om 
vilken metod av MR och DT som bäst avbildar plackkomponenter med ökad risk att orsaka 
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sjukdomsbörda. Studierna använder metoder för bildtagning, analyserar vävnad samt sina resultat 
på så skilda sätt att de inte är jämförbara. Tidigare forskning har publicerats där 
rekommendationer angivits för hur forskningen inom detta område bör genomföras, men denna 
studie förstärker behovet av ett uppdaterat, enhetligt och tydligt styrdokument som bör följas av 
kommande forskning för att kunna sammanställa och dra slutsatser inom detta medicinska 
område. Det finns dock en del data som indikerar att MR är en mer studerad metod än CT och i 
något högre grad kan påvisa komponenter med ökad risk att orsaka sjukdom.  
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Appendix 
 
Table 4. Literature search in database Pubmed for PIRO 1 (CT). Date of search: 140911.  
 
 
 
 
 
PIRO issue  Type of search Nr Search terms Items found 
P- Patient MeSH #1 "Carotid Stenosis"[Mesh] OR "Plaque, Atherosclerotic"[Mesh] 14494 
P- Patient Free-text #2 "Carotid plaque" OR "carotid stenosis" OR "carotid 
atherosclerosis" 
 
16551 
I- Index MeSH #3 "Tomography, X-Ray Computed"[Mesh]  
 
302367 
I- Index Free-text #4 "Computed tomography" OR CT  385219 
R- Reference MeSH #5 "Pathology"[Mesh] OR "Histology"[Mesh] OR "anatomy and 
histology" [Subheading] 
 
4095138 
R- Reference Free-text #6 histolog* OR patholog* OR morpholog* 3498867 
 Combination 
MeSH and free-
text 
#9 #1 OR #2 18889 
 ” #10 #3 OR #4 528363 
 ” #11 #5 OR #6 4853647 
 ” #12 
 
#9 AND #10 AND #11 908 
 ” #13 #12 AND limitations: english, humans, 10 years 640 
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Table 5. Literature search in database CENTRAL for PIRO 1 (CT). Date of search: 140913.  
 
  
PIRO issue  Type of 
search 
Nr Search terms Items found 
P- Patient MeSH #1 "Carotid Stenosis"[Mesh] OR "Plaque, Atherosclerotic"[Mesh] 655  
P- Patient Free-text #2 "carotid plaque" OR "carotid stenosis" OR "carotid 
atherosclerosis" 
 
1185 
I- Index MeSH #3 "Tomography, X-Ray Computed"[Mesh]  
 
4023 
I- Index Free-text #4 "computed tomography" OR CT  42070 
 
R- Reference MeSH #5 (("Pathology"[Mesh]) OR "Histology"[Mesh]) OR "anatomy and 
histology" [Subheading] 
 
3641  
R- Reference Free-text #6 histolog* OR patholog* OR morpholog* 57180  
 Combination 
MeSH and free-
text 
#9 #1 OR #2 1240 
 ” #10 #3 OR #4 43006 
 ” #11 #5 OR #6 57574 
 ” #12 #9 AND #10 AND #11  29 
  #13 #12 and limit: date latest 10 years and trials  
8 
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Table 6. Additional references found for PIRO 1 (CT). 
# Found via Authors, Year, Title 
1 Mats Danielsson, Professor in 
physics, Kungliga tekniska 
högskolan, Stockholm. 
Boussel, L., Coulon, P., Thran, A. et al.  
2014 
”Photon counting spectral CT component analysis of coronary artery 
atherosclerotic plaque samples” 
2 Luca Saba,  
Università degli studi di Cagliari, 
Department of Biomedical Science, 
Italy, Radiology. 
Saba, L., Lai, M. L., Montisci, R. et al.  
2012  
”Association between carotid plaque enhancement shown by multidetector CT 
angiography and histologically validated microvessel density” 
3 Luca Saba,  
Università degli studi di Cagliari, 
Department of Biomedical Science, 
Italy, Radiology. 
Saba, L., Tamponi, E., Raz, E. et al. 
 2014  
”Correlation between fissured fibrous cap and contrast enhancement: 
Preliminary results with the use of CTA and histologic validation” 
4 Reference list of 
Saam, T. 
et al, 2013. 
Appel, A. A., Chou, C. Y., Greisler, H. P. Et al.  
2012  
”Analyzer-based phase-contrast x-ray imaging of carotid plaque microstructure” 
5 Reference list of 
Vukadinovic, D. 
Et al, 2012 
de Weert, T. T., de Monye, C., Meijering, E. Et al  
2008  
”Assessment of atherosclerotic carotid plaque volume with multidetector 
computed tomography angiography” 
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Figure 1. Flow diagram for selection process for PIRO 1 (CT).  
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Table 7. List of excluded articles for PIRO 1 (CT). 
# Study 
Authors, publication year 
Reason of exclusion 
1 Wintermark, M. 
Arora, S. 
Tong, E. Et al. 2008 
Reference not according to PIRO 
2 Haraguchi, K. 
Houkin, K. 
Koyanagi, I.et al. 2008 
Reference not according to PIRO 
3 Mauriello, A. 
Sangiorgi, G. M. 
Virmani, R. et al. 2010 
Not detecting components of plaques 
4 Groen, H. C. 
van Walsum, T. 
Rozie, S. et al. 2010 
Not detecting components of plaques 
5 Korn, A. 
Bender, B. 
Thomas, C. et al. 2011 
Reference not according to PIRO (Reference not according to PIRO) 
6 Obaid, D. R. 
Calvert, P. A. 
Gopalan, D. et al. 2013 
Only coronary arteries studied. 
7 Pecoraro, F. 
Dinoto, E. 
Mirabella, D.et al. 2013 
Not detecting components of plaques 
8 Jaff, M. R. 2008 
 
Review 
9 Vukadinovic, D. 
Rozie, S. 
van Gils, M. Et al. 2012 
Reference not according to PIRO 
10 de Weert, T. T. 
de Monye, C. 
Meijering, E. Et al 2008 
Reference not according to PIRO 
11 Saba et al 2014 Not detecting relevant histologic components 
12 Saba et al 2012 Not detecting relevant histologic components 
13 Zaignon, R. Et al  2012 Ex vivo plaques 
 
14 Saam, T. Et al  2013 Ex vivo plaques 
 
15 Hetterich, H. Et al 2013 
 
Ex vivo plaques 
 
16 Appel, A.et al 2012 
 
Ex vivo plaques 
 
17 Appel, A. Et al 2012 Ex vivo plaques 
 
18 De Weert T T et al, 2005 Ex vivo plaques 
 
19 Hetterich, H. Et al 2014 
 
Ex vivo plaques 
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Table 8. Literature search in database Pubmed for PIRO 2 (MRI). Date of search: 140911.   
PIRO issue  Type of search Nr Search terms Items found 
P- Patient MeSH #1 "Carotid Stenosis"[Mesh] OR "Plaque, Atherosclerotic"[Mesh] 14494 
P- Patient Free-text #2 "Carotid plaque" OR "carotid stenosis" OR "carotid 
atherosclerosis" 
 
16551 
I- Index MeSH #3 "Magnetic Resonance Imaging"[Mesh]  308100 
I- Index Free-text #4 "Magnetic resonance imaging" OR MRI 398197 
R- Reference MeSH #5 "Pathology"[Mesh] OR "Histology"[Mesh] OR "anatomy and 
histology" [Subheading] 
 
4095138 
R- Reference Free-text #6 Histolog* OR patholog* OR morpholog* 3498867 
 Combination 
MeSH and free-
text 
#9 #1 OR #2 18889 
 ” #10 #3 OR #4 398197 
 ” #11 #5 OR #6 4853647 
 ” #12 
 
#9 AND #10 AND #11 1478 
 ” #13 #12 AND limitations: english, humans, 10 years 892 
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Table 9. Literature search in database CENTRAL for PIRO 2 (MRI) Date of search: 140913.  
 
 
 
 
 
  
PIRO issue  Type of 
search 
Nr Search terms Items found 
P- Patient MeSH #1 "Carotid Stenosis"[Mesh] OR "Plaque, Atherosclerotic"[Mesh] 655  
P- Patient Free-text #2 "carotid plaque" OR "carotid stenosis" OR "carotid 
atherosclerosis" 
 
1185 
I- Index MeSH #3 "Magnetic Resonance Imaging"[Mesh]  5666 
I- Index Free-text #4 "Magnetic resonance imaging" OR MRI 9699 
 
R- Reference MeSH #5 (("Pathology"[Mesh]) OR "Histology"[Mesh]) OR "anatomy and 
histology" [Subheading] 
 
3641  
R- Reference Free-text #6 histolog* OR patholog* OR morpholog* 57180  
 Combination 
MeSH and 
free-text 
#9 #1 OR #2 1240 
 ” #10 #3 OR #4 10003 
 ” #11 #5 OR #6 57574 
 ” #12 #9 AND #10 AND #11  56 
  #13 #12 and limit: date latest 10 years and trials 23 
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Table 10. Additional references found for PIRO 2 (MRI). 
 
# Found via Authors, Year, Title 
1 Reference list of 
Biasiolli, L. 
2013 
Chu B, 2004  
”Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study” 
2 Reference list of 
Cai, J., 2005 
Trivedi, R. A., 2004 
 ”MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for 
identifying vulnerable carotid plaques in vivo” 
3 Reference list of 
Cai, J., 2005 
Trivedi, R. A., 2004  
”Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human 
carotid atherosclerotic plaques” 
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Figure 2. Flow diagram for selection process for PIRO 2 (MRI). 
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Table 11. List of excluded articles for PIRO 2 (MRI). 
# Study 
Authors, publication year 
Reason of exclusion 
1 Arai D et al, 2011 Not detecting components of plaques 
 
2 Chan C.F., 2010 Not detecting components of plaques 
 
3 Chu B et al, 2005 Case report 
4 Demarco et al, 2010 Not comparing with histology 
5 Gao et al, 2009 Not detecting components of plaques 
 
6 Hnad P.J, 2009 Comment 
7 Hinton-Yates, D. P. 2007 Ex vivo plaques 
8 Ota H et al 2009 Not comparing wtih histology 
9 Ronen R.R et al 2007 Ex vivo plaques 
10 Anumula S, 2005 Not comparing wtih histology 
11 Saloner D, 2007 Review  
12 Boekhorst, B. C., 2012 Ex vivo plaques 
13 Zhao X et al 2010 Not comparing wtih histology 
14 Clarke, S. E. 2006 Ex vivo plaques 
15 Fabiano, S. 2008 Ex vivo plaques 
16 Trivedi RA 2004 Duplicate 
17 Hishikawa, T. 2010 Reference not according to PIRO  
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Table 12. Characteristics of included studies for PIRO 1 (CT), outcome variable AHA plaque type IV.  
    
 
Article 
reference 
number, 
Author, 
Year 
Study 
Design 
Patients(n) 
Plaque(n) 
Dropouts 
 
Gender 
(Male(M)/ 
Female(F)) 
Mean/median 
age (years) 
 
 
Type of 
patients 
(Symtomatic(S)
/ 
Assymtomatic(
A) 
Diagnostic 
tests:  
Index vs 
Reference 
Contrast 
agent 
Outcome 
variables 
reported in 
the study 
Trans-
lated 
AHA 
type 
Time 
between 
index and 
reference 
test 
Measuremen
t of 
agreement 
Quality of 
study  
!
NR= Not Reported. NS= Not Specified. DSCT= Dual source Computed Tomography. MDCT= Multidetector Computed Tomography. LC= Lipid Core. LRNC= Lipid Rich Necrotic Core. 
Outcome component reported as described in the article. Asterix (*)= outcome components translated to AHA type according to the AHA (American Heart Association) classification 
report.  
!
!
#17 
Das, M. 
2009 
Cross 
sectio
nal  
30 patients 
NR 
0 26 M 
4 F 
Mean:  
70 (52-85) 
30 S 
0 A 
DSCT vs 
Histology 
Yes  
(Iodine 
and 
saline-
chaser) 
AHA IV/V  IV/V  
 
2 days Cohens 
cappa 
 
Low 
#16 
De Weert, 
T. 
2006 
Cross 
sectio
nal  
15 patients 
15 plaques 
1 6 M 
9 F 
Mean:  
70,3 (62-84) 
15 S 
0 A 
MDCT  
vs 
Histology 
Yes  
(NS) 
LC+ 
hemorrhage
+ Necrotic 
debris                
IV* 
 
3 months Linear 
regression 
analysis 
Bland 
Altman plot 
Moderate 
#15 
Wintermark
, M.      
2008 
Cross 
sectio
nal  
8 patients 
8 plaques 
0 8 M 
0 F 
Mean:  
62 (55-69) 
8 S 
0 A 
MDCT vs 
Histology 
Yes 
(Iodine) 
 LRNC 
 
IV* 
 
1-5 days Cohens 
kappa  
Moderate 
!
Table 13. Characteristics of included studies for PIRO 1 (CT), outcome variable AHA plaque type V.  
    
 
Article 
reference 
number, 
Author, 
Year 
Study 
Design 
Patients(n) 
Plaque(n) 
Dropouts 
 
Gender 
(Male(M)/ 
Female(F)) 
Mean/median 
age (years) 
 
 
Type of 
patients 
(Symtomatic(S)
/ 
Assymtomatic(
A) 
Diagnostic 
tests:  
Index vs 
Reference 
Contrast 
agent 
Outcome 
variables 
reported in 
the study 
Trans-
lated 
AHA 
type 
Time 
between 
index and 
reference 
test 
Measuremen
t of 
agreement 
Quality of 
study  
!
!
NR= Not Reported. NS= Not Specified. DSCT= Dual Source Computed Tomography. MDCT= Multidetector Computed Tomography. LC= Lipid core. LRNC= Lipid Rich Necrotic Core. FT= 
Fibrous Tissue. Outcome component reported as described in the article. Asterix (*)= outcome components translated to AHA type according to the AHA (American Heart Association) 
classification report.!
 
# 36 
Ajduk, M. 
2013 
Cross 
sectio
nal  
50 patients 
50 plaques 
0 36 M 
14 F 
Median:  
69 (48-87) 
20 S 
30 A 
MDCT vs 
Histology 
Yes 
(Iopamidol) 
AHA V V 1 week Sensitivity, 
specificity 
Moderate 
#17 
Das, M.,  
2009 
Cross 
sectio
nal  
30 patients 
NR 
0 26 M 
4 F 
Mean:  
70 (52-85) 
30 S 
0 A 
DSCT vs 
Histology 
Yes  
(Iodine and 
saline-
chaser) 
AHA IV/V  IV/V  
 
2 days Cohens 
kappa  
Low 
#16 
De Weert, 
T.         
2006 
Cross 
sectio
nal  
15 patients 
15 plaques 
1 6 M 
9 F 
Mean:  
70,3 (62-84) 
15 S 
0 A 
MDCT  
vs 
Histology 
Yes  
(NS) 
FT 
area+tuni
ca media 
V* 3 months Linear 
regression 
analysis 
Bland 
Altman plot 
Moderate 
#14 
Horie, N. 
2012 
Cross 
sectio
nal  
51 patients 
59 plaques 
39 46 M 
5 F 
Symtomatic 
mean: 71,84 
(+/- 8,5) 
Assymtomatic 
mean: 67,8 
(+/- 9,1) 
33 S 
18 A 
MDCT vs 
Histology 
Yes  
(NS) 
FT 
 
 
V* 2 weeks Linear 
regression 
analysis 
Pearson 
rank 
correlation 
test  
Moderate 
#15 
Wintermark
, M.      
2008 
Cross 
sectio
nal  
8 patients 
8 plaques 
0 8 M 
0 F 
Mean:  
62 (55-69) 
8 S 
0 A 
MDCT vs 
Histology 
Yes 
(Iodine) 
Fibrous 
cap 
thickness 
V* 1-5 days Linear 
regression 
analysis 
 
Moderate 
!
Table 14. Characteristics of included studies for PIRO 1 (CT), outcome variable AHA plaque type VI.  
    
 
Article 
reference 
number, 
Author, 
Year 
Study 
Design 
Patients(n) 
Plaque(n) 
Dropouts 
 
Gender 
(Male(M)/ 
Female(F)) 
Mean/median 
age (years) 
 
 
Type of 
patients 
(Symtomatic(S)
/ 
Assymtomatic(
A) 
Diagnostic 
tests:  
Index vs 
Reference 
Contrast 
agent 
Outcome 
variables 
reported in 
the study 
Trans-
lated 
AHA 
type 
Time 
between 
index and 
reference 
test 
Measuremen
t of 
agreement 
Quality of 
study  
!
 
NR= Not Reported. NS= Not Specified. DSCT= Dual Source Computed Tomography. MDCT= Multidetector Computed Tomography. LC= Lipid Core. LRNC= Lipid Rich Necrotic Core. 
Outcome component reported as described in the article. Asterix (*)= outcome components translated to AHA type according to the AHA (American Heart Association) classification 
report.  
#37 
Ajduk, M.  
2008 
Cross 
sectio
nal  
31 patients 
31 plaques 
0 21 M 
10 F 
Median:  
70 (51-87) 
6 S 
25 A 
MDCT vs 
Histology 
Yes 
(Iopamidol
) 
 AHA Vib VI 
 
1 week Sensitivity, 
specificity 
Moderate 
#36 
Ajduk, M. 
2013 
Cross 
sectio
nal  
50 patients 
50 plaques 
0 36 M 
14 F 
Median:  
69 (48-87) 
20 S 
30 A 
MDCT vs 
Histology 
Yes 
(Iopamidol
) 
AHA VIb VI 1 week Sensitivity, 
specificity 
Moderate 
#17 
Das, M. 
2009 
Cross 
sction
al  
30 patients 
NR 
0 26 M 
4 F 
Mean:  
70 (52-85) 
30S 
0A 
DSCT vs 
Histology 
Yes  
(Iodine 
and 
saline-
chaser) 
AHA VI VI 2 days Cohens 
kappa  
Low 
#14 
Horie, N. 
2012 
Cross 
sectio
nal  
51 patients 
59 plaques 
39 46 M 
5 F 
Symtomatic 
mean: 71,84 
(+/- 8,5) 
Assymtomatic 
mean: 67,8 
(+/- 9,1) 
33 S 
18 A 
MDCT vs 
Histology 
Yes  
(NS) 
LRNC+ 
hemorrage 
 
VI* 2 weeks Linear 
regression 
analysis 
Pearson 
rank 
correlation 
test  
Moderate 
#15 
Wintermark
, M.      
2008 
Cross 
sectio
nal  
8 patients 
8 plaques 
0 8 M 
0 F 
Mean:  
62 (55-69) 
8 S 
0 A 
MDCT vs 
Histology 
Yes 
Iodine 
IPH VI* 1-5 dagar Cohens 
cappa  
Moderate 
Table 15. Characteristics of included studies for PIRO 2 (MRI), outcome variable AHA plaque type IV.  !
 
Article 
reference 
number, 
Author,  
Year 
Study 
Design 
Patients(n) 
Plaque(n) 
Dropout
s 
 
Gender 
(Male(M)/ 
Female(F)
) 
Mean/median 
age (years) 
 
 
Type of 
patients 
(Symto
matic(S)
/Assymt
omatic(
A) 
Diagnostic 
tests: Index vs 
Reference 
Contrast 
agent 
Outcome 
variables 
reported in 
the study 
Trans-
lated 
AHA 
type 
Time 
between 
index and 
reference 
test 
Measurem
ent of 
agreement 
Quality of 
study  
!
NR= Not Reported. NS= Not Specified. NC= Necrotic Core. LC= Lipid Core. LRNC= Lipid Rich Necrotic Core. IPH= Intra Plaque Hemorrhage. Outcome component reported as described 
in the article. Asterix (*)= outcome components translated to AHA type according to the AHA (American Heart Association) classification report.  
# 32 
Kerwin, 
WS.     
2006 
Cross 
section
al  
30 
NR 
3 29 M 
1 F 
Mean: 67.7 ± 
10.7      
Range: 48–83  
NS 1.5-T MR 
without cardiac 
gating vs 
histology 
Yes, 
(Gadolinu
m) 
NC 
 
IV* 1 week Pearson 
correlation 
coeffiscien
t 
Moderate 
# 31           
Saam T.  
2005 
Cross 
section
al  
40 
NR 
9 38 M 
2 F 
Mean: 68     
SD 9  
 
NS 
 
1.5 T MR 
phased array 
surface vs 
histology 
- LRNC 
 
 
IV*  1 week Sensitivity 
specificity, 
cohens 
cappa, 
pearsons 
rank test 
High 
# 29 
Trivedi R. 
2004 
Cross 
section
al  
40 
NR 
18 28 M 
12 F 
mean age 71, 
range 45–88 
years) 
40 S 
/ 
0 A 
1.5 T MR 
custumized 4 
channel phased 
array coil vs 
hisology 
- FC+LC IV*/V* NR Bland 
Altman 
plot 
Low 
# 34 
Yoshida K. 
2007 
Cross 
sctiona
l  
70 
NR 
38 61 M 
9 F 
Median: 69; 
Range: 53– 80 
 
48 
/ 
22 
1.5 T MR with 8 
cm surface coil 
vs Histology 
- Soft plaques  IV* 
 
2 weeks Sensitivity, 
specitivity 
 
Moderate 
# 35    
Young V E. 
2009 
Cross 
sctiona
l  
28 
NR 
9 21 M 
7 F 
Mean: 73 
Range 54–87  
 
14 
/ 
12 
1.5 T MR 
bilateral 4 
channel phased 
array carotid coil     
vs histology 
- LRNC 
 
IV* NR Sensitivity, 
specitivity 
 
Moderate 
Table 16. Characteristics of included studies for PIRO 2 (MRI), outcome variable AHA plaque type V. !
 
Article 
reference 
number, 
Author,  
Year 
Study 
Design 
Patients(n) 
Plaque(n) 
Dropouts 
 
Gender 
(Male(M)/ 
Female(F)) 
Mean/median 
age (years) 
 
 
Type of 
patients 
(Symtom
atic(S)/As
symtomat
ic(A) 
Diagnostic tests: 
Index vs 
Reference 
Contrast 
agent 
Outcome 
variables 
reported in 
the study 
Trans-
lated 
AHA 
type 
Time 
between 
index and 
reference 
test 
Measuremen
t of 
agreement 
Quality of 
study  
!
NR= Not Reported. NS= Not Specified. FT= Fibrous Tissue. FC= Fibrous Cap.Outcome component reported as described in the article. Asterix (*)= outcome components translated to 
AHA type according to the AHA (American Heart Association) classification report.  
 !!
 
# 32 
Kerwin, 
WS.     2006 
Cross 
sectional  
30 
NR 
3 29 M 
1 F 
Mean: 67.7 ± 
10.7       
Range: 48–83  
NS 1.5-T MR 
without 
cardiac gating 
vs histology 
Yes, 
(Gadolinum) 
FT V* 1 week 
 
Pearson 
correlation 
coefficients 
Moderate 
# 31  Saam 
T.  2005 
Cross 
sectional  
40 
NR 
9 38 M 
2 F 
Mean: 68      
SD: 9  
 
NS 
 
1.5T MR and 
phased-array 
surface vs 
histology 
- Dense 
fibrous 
tissue 
V* 1 week Pearson 
correlation 
coeffiscient 
High 
# 29 Trivedi 
R. 2004 
Cross 
sectional  
40 
NR 
18 28 M 
12 F 
mean age 71, 
range 45–88 
years) 
40 S 
/ 
0 A 
1.5 T MR 
custumized 4 
channel 
phased array 
coil vs 
hisology 
- FC+LC IV*/V* NR Bland 
Altman plot 
Low 
Table 17. Characteristics of included studies for PIRO 2 (MRI), outcome variable AHA plaque type VI. !!
 
Article 
reference 
number, 
Author,  
Year 
Study 
Design 
Patients(n) 
Plaque(n) 
Drop-
outs 
 
Gender 
(Male(M)/ 
Female(F) 
Mean/median 
age (years) 
 
 
Type of 
patients 
(Symtom-
atic(S)/ 
Asymtom
atic(A) 
Diagnostic 
tests: Index 
vs Reference 
Contrast 
agent 
Outcome 
variables 
reported in 
the study 
Trans-
lated 
AHA 
type 
Time 
between 
index and 
reference 
test 
Measure-
ment of 
agreement 
Quality of 
study  
!
NR= Not Reported. NS= Not Specified. LC= Lipid Core. IPH= Intra Plaque Hemorrhage. Outcome component reported as described in the article. Asterix (*)= outcome components 
translated to AHA type according to the AHA (American Heart Association) classification report.  !
# 33      
Altaf N. 
2013  
Cross 
sectional ! 35 
NR! 0! 24 M 11 F! Mean: 69 +/- 10! 35 / 
0!
Coronal T1-
weighted 
magnetization-
prepared 3D 
gradient echo 
sequence MRI 
vs Histology!
-! AHA VI! VI! Mean: 
20,5 days 
(8-33)! Sensitivity, Specificity, PPV, NPV! Moderate!
# 30      
Chu B. 
2004 
Cross 
sectional ! 27 
NR! 3! 21 M 6 F! Years span: 55-82! 13 / 
14!
1.5-T MRI with 
phased-array 
surface coil vs 
histology!
-! IPH! VI*! 1 week!! Sensitivity, Specificity, Cohens 
kappa 
High!
# 32 
Kerwin, 
WS.      
2006 
Cross 
sectional ! 30 
NR! 3! 29 M 1 F! Mean: 67.7 ± 10.7       Range: 48–83 !
NS! 1.5-T MR 
without 
cardiac gating 
vs histology!
Yes, 
(Gadolinu
m)!
Hemorrhage! VI*! 1 week!! Pearson correlation coefficients 
!
Moderate!
# 31            
Saam T 
2005! Cross sectional ! 40 NR! 9! 38 M 2 F! Mean: 68     SD: 9  !
NS ! 1.5T MR and phased-array surface vs 
histology!
"! Hemorrhage! VI*! 1 week!! Sensitivity, Specificity, Cohens 
kappa 
Pearson 
correlation 
coeffiscient!
High!
# 38      
Saito A . 
2012 
Cross 
sectional ! 31 
NR! 10! 30 M 1 F! Mean: 69.6 Range: 54–80 ! 25 / 
6!
1.5- T MR with 
8-channel 
neurovascular 
coil vs 
histology 
"! Lipid/necrosi
s+ 
hemorrhage   
!
IV* ! 1 week! Sensitivity, specitivity, !
Moderate!
Table 18. Analyze table for PIRO 1 (CT), outcome variable AHA plaque type IV.  
 
 
 
Article 
reference 
number, 
Author, 
Year 
Type of 
CT 
 
Outcome 
component 
AHA 
type 
Density 
(Houndsfield 
values) 
Cutoff 
HU-value 
Coefficient of 
determination 
Persons 
rank test 
Cohens 
cappa  
Sensi-
tivity 
Speci-
ficity 
Inter(a)/ 
Intra(b) 
variability 
Comments 
!
MDCT= Multidetector Computed tomography. DSCT= Dual Source Computed Tomography. FT= fibrous tissue, LC= lipid core, LRNC= Lipid rich necrotic core. NR= Not reported. ROI= 
Region of interest. Asterix (*) means outcome component translated to AHA type according to the AHA (American Heart Association) classification report.  
#17       
Das, M.  
2009 
DSCT 
with 
contrast 
AHA IV/V IV/V  
 
Fatty-(<50HU) 
Mixed (50-119 
HU) Calcified 
(>120HU) 
- - - 0,86  - - NR HU values predefined 
#16           
De Weert, 
T.         
2006 
MDCT 
with  
contrast 
Lipid+ 
hemorrhage 
+ necrotic 
debris = LC   
IV* 
 
LC (-20-60 HU) 
 
LRNC- FT: 
60 HU 
R2: 0,24 
P<0.002 
- - - - a) 20% 
b) NR  
Coefficients of 
variation in % for 
interobserver 
variability. 
#15 
Wintermark
, M.      
2008 
MDCT 
with 
contrast 
LRNC 
 
IV* 
 
LRNC: 33.6 
SD:20.0  CI:-7.4-
72.5 
LRNC- FT: 
39,5 
 
- - 1) Small 
LC: K= 
0.495; P 
<0.492        
2) Large 
LC K= 
0.796; P < 
0.001      
- - NR - 
Table 19. Analyze tables for PIRO 1 (CT), outcome variable AHA plaque type V.  
 
 
 
Article 
reference 
number, 
Author, 
Year 
Type of 
CT 
 
Outcome 
component 
AHA 
type 
Density 
(Houndsfield 
values) 
Cutoff 
HU-value 
Coefficient of 
determination 
Persons 
rank test 
Cohens 
cappa  
Sensi-
tivity 
Speci-
ficity 
Inter(a)/ 
Intra(b) 
variability 
Comments 
!
 
MDCT= Multidetector Computed tomography. DSCT= Dual Source Computed Tomography. IPH= Intra plaque hemmorrhage, FT= fibrous tissue, LC= lipid core, LRNC= Lipid rich 
necrotic core. NR= Not reported. ROI= Region of interest. Asterix (*) means outcome components translated to AHA type according to the AHA (American Heart Association) 
classification report. 
 
  
# 36   
Ajduk, M. 
2013 
MDCT 
with 
contrast 
AHA V V Median range: 
44.9 (-23.6-150) 
Cut off: 
38.9 
- - - 63.2% 
(p=0.03
5) 
80.6% 
(p=0.03
5) 
NR ROC analyse was 
used to determine cut-
off HU-value 
#17       
Das, M. 
2009 
DSCT 
with 
contrast 
AHA IV/V IV/V  
 
Fatty-(<50HU) 
Mixed (50-119 
HU) Calcified 
(>120HU) 
- - - 0,86  - - NR HU values predefined 
#16           
De Weert, 
T.         
2006 
MDCT 
with  
contrast 
FT+tunica 
media 
V* FT (60-140 HU) LRNC- FT: 
60 HU 
R2: 0,76 
P<0.001 
 
- - - - a) 10%  
b) NR 
Coefficients of 
variation in % for 
interobserver 
variability. 
#14    
Horie, N. 
2012 
MDCT 
with 
contrast 
FT 
 
V* 
 
ΔHU 
Symtomatic: 5.6 
HU +/- 10.2 
Asymtomatic: 
13.5 HU +/-14.5 
(p=0.02) 
NS - ΔHU  r=0.67  
P=0.001 
 
- - - NR ΔHU= early phase 
contrast/ late phase 
contrast 
#15 
Wintermark
, M.      
2008 
MDCT 
with 
contrast 
Fibrous cap 
thickness 
V* 
 
FT: 46.4 SD. 
19.9   CI: (-6.6-
86.2) 
LRNC- FT: 
39,5 
FT- IPH: 
72.0 
R2= 0.77 
P<0.001 
- - - - NR - 
Table 20. Analyze table for PIRO 1 (CT), outcome variable AHA plaque type VI.  
 
 
 
Article 
reference 
number, 
Author, 
Year 
Type of 
CT 
 
Outcome 
component 
AHA 
type 
Density 
(Houndsfield 
values) 
Cutoff 
HU-value 
Coefficient of 
determination 
Persons 
rank test 
Cohens 
cappa  
Sensi-
tivity 
Speci-
ficity 
Inter(a)/ 
Intra(b) 
variability 
Comments 
!
MDCT= Multidetector Computed tomography, DSCT= Dual Source Computed Tomography. IPH= Intra plaque hemmorrhage, FT= fibrous tissue, LRNC= Lipid rich necrotic core, NR= 
Not reported. Asterix (*) means outcome components translated to AHA type according to the AHA (American Heart Association) classification report.  
#37   
Ajduk, M.  
2008 
MDCT 
with 
contrast 
AHA VIb 
 
VI 
 
Plaques with 
IPH Vib: 22 
(range -17-31) 
Plaques without 
IPH: 59 (range-
6-150) 
Cut off: 
IPH: 31 
- - - 100%  
 
64,7% NR ROC analyse was 
used to determine cut-
off HU-value 
# 36   
Ajduk, M. 
2013 
MDCT 
with 
contrast 
AHA VIb 
 
VI Plaques with 
IPH Vib: 14.7 
(range -17.6- 
31.8) Plaques 
without IPH: 
54.3 (range-
23.6- 150) 
Cut off: 
IPH: 33,8 
- - - 100%  
 
70.4% NR ROC analyse was 
used to determine cut-
off HU-value 
#17       
Das, M. 
2009 
DSCT 
with 
contrast 
AHA VI VI Fatty-(<50HU) 
Mixed (50-119 
HU) Calcified 
(>120HU) 
- - - 0,81  - - NR HU values predefined 
#14    
Horie, N. 
2012 
MDCT 
with 
contrast 
LRNC + IPH VI* ΔHU 
Symtomatic: 5.6 
HU +/- 10.2 
Asymtomatic: 
13.5 HU +/-14.5 
(p=0.02) 
NS - ΔHU r=-0,7 
P=0.001 
- - - NR ΔHU= early phase 
contrast/ late phase 
contrast 
#15 
Wintermark
, M.      
2008 
MDCT 
with 
contrast 
IPH VI* Hemorrhage: 
97.5 SD. 22.0 
CI: (53.5-141.6) 
FT- IPH: 
72.0 
 
- - 1) Large 
IPH: K= 
0.712; 
P<0.102 
2) 
Ulceration 
K= 0.855 
- - NR - 
Table 21. Analyze table for PIRO 2 (MRI), outcome variable AHA plaque type IV.  
 !
 
Article 
reference 
number, 
Author, 
Year 
Type of MR 
sequence 
 
Outcome 
component 
Trans-
lated 
AHA 
type 
Cut off value Pearson 
correlation 
coeffiscient 
Bland 
Altman Plot 
Cohens 
cappa 
statistic
s 
Sensi-
tivity 
Speci-
ficity 
 
PPV NPV Inter(a)/ 
intra(b) 
observer 
variability 
Comments 
 
!
NC= Necrotic core. LRNC= Lipid rich necrotic core. FC= Fibrous cap. NS= Not specified. PPV= Positive predictive value. NPV= Negative predictive value. NR= Not reported. Asterix (*) 
means outcome components translated to AHA type according to the AHA (American Heart Association) classification report. 
# 32         
Kerwin, 
WS.          
2006 
1.5-T MR 
transverse 2D 
spoiled gradient-
recalled- echo 
sequence 
NC IV* - Vp: r=-0,26 
p=NS               
K-trans: r=-0,05 
p=NS 
 - - - - - - Vp= plasma volume 
K-trans= transfer 
constant 
# 31            
Saam T.  
2005 
1.5 T MR with 
phased-array 
surface coil 
LRNC IV* - r= 0.75 p<0.001 - 0.73 95% 76% - - a) 0.89   
b) 0.92 
- 
# 29          
Trivedi R.    
2004 
1.5-T with 
customized 4 
channel phased 
array coil 
FC+LC IV*/V* - - 95% of 
values within 
2 SD from 
the mean 
diff erence in 
ratios 
(0.02±0.04) 
-  - - - - a) 0.87         
b) NR 
- 
# 34 
Yoshida 
K.      
2007 
1.5 T MR with 8-
cm diameter 
surface coil 
Soft plaque VI* 1.25 (mean of 
roSI) 
-  - 79.4% 84.4% - - - rSI (relative signal 
intensity)= SI 
component/SI 
reference.        
roSI= SI whole 
plaque/SI ref.        
T1 weighted 
images. 
# 35           
Young V 
E.       
2009 
1.5-T MR with 
bilateral four-
channel phased-
array carotid coil 
LRNC IV* 
 
 
- 
 
-  - 86% 
 
40% 
 
- - a) 0.60    
b) NR 
Cohens kappa: lipid 
staining on 
histology correlating 
with a lower ADC 
(apparent diffusion 
coefficient) value. 
Table 22. Analyze table for PIRO 2 (MRI), outcome variable AHA plaque type V.  
 !
 
Article 
reference 
number, 
Author, 
Year 
Type of MR 
sequence 
 
Outcome 
component 
Trans-
lated 
AHA 
type 
Cut off value Pearson 
correlation 
coeffiscient 
Bland 
Altman Plot 
Cohens 
cappa 
statistic
s 
Sensi-
tivity 
Speci-
ficity 
 
PPV NPV Inter(a)/ 
intra(b) 
observer 
variability 
Comments 
 
!
 
= Fibrous tissue. FC= Fibrous cap. LC= Lipid core. PPV= Positive predictive value. NPV= Negative predictive value. Asterix (*) means outcome components translated to AHA type 
according to the AHA (American Heart Association) classification report. 
# 32         
Kerwin, 
WS.          
2006 
1.5-T MR 
transverse 2D 
spoiled gradient-
recalled- echo 
sequence 
FT V* - Vp: r=0.18 p=NS             
K-trans: r=-0.02 
p=NS 
- - - - - - Vp= plasma 
volume K-trans= 
transfer constant 
# 31            
Saam T.  
2005 
1.5 T MR with 
phased-array 
surface coil 
Dense 
fibrous 
tissue 
V* - r=0.55 p=0.001 - - - - - - - - 
# 29          
Trivedi R.    
2004 
1.5-T with 
customized four-
channel phased 
array coil 
FC+LC IV*/V* - - 95% of 
values within 
2 SD from 
mean diff 
erence in 
ratios 
(0.02±0.04) 
- -  -  - a) 0.87        
b) NR 
 
- 
Table 23. Analyze table for PIRO 2 (MRI), outcome variable AHA plaque type VI.  
 
 !
 
Article 
reference 
number, 
Author, 
Year 
Type of MR 
sequence 
 
Outcome 
component 
Trans-
lated 
AHA 
type 
Cut off value Pearson 
correlation 
coeffiscient 
Bland 
Altman Plot 
Cohens 
cappa 
statistic
s 
Sensi-
tivity 
Speci-
ficity 
 
PPV NPV Inter(a)/ 
intra(b) 
observer 
variability 
Comments 
 
!
IPH= Intra Plaque Hemorrhage. NR= Not reported. SE= non-gated spin echo sequence. BB= cardiac-gated black-blood sequence. MPRAGE= fast-SE magnetization-prepared rapid 
acquisition with gradient echo sequence. SI-MRA= source image of three-dimensional time-of-flight MR angiography sequence. PPV= Positive predictive value. NPV= Negative 
predictive value. Asterix (*) means outcome components translated to AHA type according to the AHA (American Heart Association) classification report.  
# 33             
Altaf N.       
2013  
Coronal 3D 
gradient echo 
sequence MR 
AHA VI VI - - - - 82% 79% 90% 64% Cohens K 
a) 0.88    
b) 0.81 
- 
# 30              
Chu B.        
2004 
1.5-T MR with 
phased-array 
surface coil 
IPH VI* - - - Reader 
1: 0.74 
Reader 
2: 0.52 
90% 74% - - Cohens K 
a) 0.4      
b) NR 
- 
# 32         
Kerwin, 
WS.          
2006 
1.5-T MR 
transverse 2D 
spoiled gradient-
recalled- echo 
sequence 
Hemorrhage VI* - Vp: r=-0.01 
p=NS               
K-trans: r=0.26 
p=NS 
- - - - - - - Vp= plasma 
volume K-trans= 
transfer constant 
# 31            
Saam T.  
2005 
1.5 T MR with 
phased-array 
surface coil 
Hemorrhage VI* - r= 0.66 p<0.001 - 0.71 87% 84% - - a) 0.74    
b) 0.73 
- 
# 38            
Saito A.      
2012  
1.5- T MR with 
eight-channel 
neurovascular coil 
Lipid/ 
necrosis 
with 
Hemorrhage 
 
VI* 
 
 
SE: 1.19        
BB: 1.11  
MPRAGE: 
1.08 SI-MRA: 
1.10 
- - - SE: 
100%
BB: 
75% 
MPRA
GE: 
88% 
SI-
MRA: 
100% 
SE: 
100%
BB: 
100%
MPRA
GE: 
100%
SI-
MRA: 
80% 
- - a) NR     
b)  0.98–
0.99 
(median, 
0.99) and 
0.95– 0.99 
(median, 
0.98),  
Analyzed four 
kinds of T1W 
images Analyzed 
lipid+necrosis+ 
hemorrage vs FT 
Table 24. Diversity between methods for studies of PIRO 1 (CT).  
Article 
reference 
number, 
Author, 
Year 
Method to measure density Method to define density  
 
Landmarks used 
to match 
histology and 
imaging slices 
Method 
of CEA 
Extraction 
of calcium  
Contrast administration 
 
Method of 
histological 
assessment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CEA= Carotid endarterectomy. ROI= Region of interest. HU= Hounsfield Units. LC= Lipid core. FT= fibrous tissue. NR= Not reported. NS= Not specified. 
#37 
Ajduk, M.  
2008 
Manually by measuring density three 
times on the visually least dense area 
at the level of maximal stenosis 
Median tissue density of type VIb vs 
other plaques. 
Cut-off value for type Vib was 
determined by ROC analysis. 
Distance between 
carotid bifurcation 
and level of 
maximal stenosis. 
 
NR No A standardized optimized, contrast-
enhanced protocol was used with 
intermediate reconstruction: 120 kVp, 
120 mAs, collimation 16 x 0.75 mm, 
pitch 1. Iopamidol was administrated 
370 mg iodine/mL, 4 mL/sec, 70 
mm3, 325 psi. 
Manual 
# 36 
Ajduk, M. 
2013 
Manually by measuring density three 
times on the visually least dense area 
at the level of maximal stenosis 
Median tissue density of type VIb vs 
other plaques.  
Cut-off value for type Vib and V was 
determined by ROC analysis. 
Distance between 
carotid bifurcation 
and level of 
maximal stenosis. 
 
NR No A standardized optimized, contrast-
enhanced protocol was used with 
intermediate reconstruction: 120 kVp, 
120 mAs, collimation 16 x 0.75 mm, 
pitch 1. Iopamidol was administrated 
370 mg iodine/mL, 4 mL/sec, 70 
mm3, 325 psi. 
Manual 
#17 
Das, M. 
2009 
Manually by measuring Hounsfield 
densities for each part of the 
plaque by using 
a pixel lens. 
Cut-off values was predefined: 
< 50 HU = fatty  
50-119 HU= mixed  
>120 HU=calcified  
NR NR No A test bolus was performed to assess 
the optimal bolus timing prior to the 
scan. The optimal scan delay was 
assessed after graphical resentation 
of peak enhancement at the aortic 
arch.  
Manual 
#16 
De Weert, 
T. 
2006 
A combination of manual and 
cumputerised processing: 
A ROI was manually drawn on 
histological slices and corresponding 
CT slices. A custommade plug-in for the 
software (ImageJ) determined different 
component areas within the ROI. 
Hounsfield values was measured for LC 
and FT in all plaques and based on the 
distribution, cutoff values was 
determined between LC and FT. 
Shape of the 
lumen and vessel 
wall, the location 
of the bifurcation, 
and the presence 
of calcifications 
 
NR No A standardized optimized contrast-
enhanced 
protocol was used with 120 kVp, 180 
mAs, collimation 16$0.75 mm, table 
feed 
12 mm/rotation, pitch 1. 
Manual 
#14 
Horie, N. 
2012 
Manually by free-hand rating and 
measuring segmentation of the ROI in 
each plaque. The mean HU in the ROI 
was measured early and delayed 
contrast phase. 
Studying dynamic plaque 
enhancement. 
No cut-off value for differentiation of 
specific components. 
NR NR Yes 
(Severe 
calcified 
component
s covering 
the vessel 
wall was 
excluded 
from 
the ROI) 
Two-phase contrast-enhanced CT 
was performed in the early- and 
delayed phase (2 minutes interval). 
An automatic bolus-tracking program 
was used to start acquisition after 
contrast injection. Iohexol, was 
administered with injection rate of 3.5 
ml/s, for a total volume of 70 ml 
followed by a saline chaser of 40 ml. 
Manual 
#15 
Wintermark
, M.       
2008 
A computer algoritm, developed by the 
authors, segmented contours of the 
artery, calculated HU thresholds and 
colored the components after 
composition. The color overlays was 
manually reviewed.  
 
Average HU in each pixel compared 
with percentage of each component in 
corresponding histologic squares.  
Cut-off determined by the halfway 
attenuation between the mean densities 
for each component. 
Overall 
morphologic 
features and the 
distance from the 
carotid bifurcation 
NR No Optimal timing of acquisition was 
achieved with test bolus technique. 
70 mL Iohexol was injected with a 
injector rate of 4 mL/s.  
 
Manual 
Table 25. Diversity between methods for studies of PIRO 2 (MRI).  
Article 
reference 
number, 
Author, 
Year 
MRI protocool Contrast 
administration 
Method to detect components Landmarks used to 
match histology and 
imaging slices  
Method of CEA Method of histologic 
assessment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCM= Sternocleidomastoideus muscle. NR= Not reported. NS= Not specified. ROI= Region of interest. 
# 33                
Altaf N.          
2013  
 
A predetermined protocol 
optimized to detect 
hemorrhage (NS) 
 
-  Not described NS Standard 
endartecectomy 
(plaque incised and 
subsequently removed) 
Semiquantitative analysis as 
recommended by Lovett JK, 
et al 2005  
# 30                 
Chu B.           
2004 
A standardized protocol 
(NS) 
 
- Manually defining intensity of 
tissue with the adjacent SCM 
muscle as reference. 
Carotid bifurcation and 
morphological features of 
lumen, vessel wall and 
calcifications 
NS 
 
Manually 
 
# 32            
Kerwin, WS.          
2006 
 
 
A generalized kinetic 
model for dynamic 
contrast enhanced MR 
imaging was used to 
quantify contrast agent 
dynamics 
Gadolinium-based 
contrast agent per 
kg, injection rate: 2 
mL/sec  
Manually by comparing intensity 
of contrast in the jugular vein to 
intensity within the plaque. 
Carotid bifurcation and overall 
shape of the lumen and plaque 
NS 
 
Manual drawing technique  
 
# 31                    
Saam T.          
2005 
A stardardized protocol 
(Yuan C, et al 2001) 
optimized for examining 
bilateral carotid arteries  
- A custom designed imaging 
analysis tool (QVAS) was used 
to perform area measurements. 
SCM was used a reference for 
intensity. 
Carotid bifurcation, lumen size 
and shape, wall size and 
shape, plaque configuration 
and calcifications 
NS 
 
Manually  
 
# 38               
Saito A.         
2012  
  
NR - The ROI was manually defined 
but analyzed with a software 
(zioTerm2009).  
SCM was used a reference for 
intensity. 
NS 
 
NS 
 
The ROI was manually 
defined but analyzed with a 
software (ImageJ Ver. 1.44) 
 
# 29             
Trivedi R.        
2004 
NR  
 
- Qualitative characterization was 
performed manually.  
Quantitative measurements  
Was performed by using (BIR, 
Mayo Clinic) software. 
Carotid bifurcation, size and 
shape of the lumen and relative 
position of the external carotid 
artery intima 
NS 
 
By using software (Leica 
Microsystems) on 
computerized images 
captured with a 1.6-
magnification lens 
# 34           
Yoshida K.     
2007 
NR  
 
- Manually. SCM was used a 
reference for intensity on T1-
weighted and the 
submandibular gland on T2-
weighted images. 
 
Carotid bifurcation and size and 
shape of the lumen and plaque 
Without placement of 
an incision 
whenever possible 
 
Manually by a operator-
defined ROI 
# 35              
Young V E.     
2009 
NR - Both the CMR Tools software 
(Cardiovascular Imaging 
Solutions Ltd) and a software 
developed by the authors 
providing intensity values for 
each pixel. SCM was used a 
reference for intensity. 
NS 
 
NS 
 
Manually 
